Assessment of Improvement in Food Sensitivity Related Symptoms on Employment of Personalized Elimination Diet
Overview
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Vibrant America Clinical Lab
- Enrollment
- 80
- Locations
- 9
- Primary Endpoint
- Improvement in severity of food sensitivity symptoms
Overview
Brief Summary
The goal is to identify food sensitivity in patients and assess whether the avoidance of the reaction-inducing foods via an 'elimination diet' leads to improvement in patient symptoms and overall well-being.
Detailed Description
After seeking appropriate consent, patients' blood samples will be tested for the reactivity toward 262 foods using peptide and protein microarrays. Food protein extraction will be carried out in different solvents such as water and alcohol. The peptide microarrays will synthesize the entire food proteins as peptides in situ while the protein microarrays will test for water-soluble and alcohol-soluble fractions. Thus, food sensitivity testing will be carried out at 3 different levels including water-soluble proteins, alcohol-soluble proteins, and peptides. Patients' blood samples can be tested at all 3 levels or a combination of these. This decision lies at the discretion of the physician.
Based on the test results and as per the physician's recommendations, a suitable elimination diet will be suggested to the patient. Personalized diet suggestions for each patient will be made by the physician. The patient will follow the diet for 4 weeks and blood samples will be tested again on completion of the diet, using peptides and protein microarrays. Additionally, based on the physician's recommendations, the time duration for which a patient follows the personalized elimination diet can be modified.
The patients will periodically have to fill out diagnostic questionnaires which will help assess the changes in their food sensitivity-related symptoms. Changes in the blood biomarkers and improvement in symptoms will be monitored during the study.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Other
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients aged between 18 to 65 years.
- •Patients suffering from food sensitivity symptoms
- •Patients having Immunoglobulin G (IgG) and Immunoglobulin A (IgA)-mediated food reactions leading to food sensitivity
- •Patients agreeing to follow the diet per testing
- •Patients willing to provide an informed consent
Exclusion Criteria
- •Patients suffering from chronic medical conditions like cancer
- •Pregnant subjects
- •Patients who have recently used antibiotics
- •Patients who have previously undergone treatments for food allergies/sensitivities
- •Patients who have been assigned an elimination diet before
- •Patients who are already following a restricted diet of any kind
- •Patients unwilling/unable to provide informed consent
Outcomes
Primary Outcomes
Improvement in severity of food sensitivity symptoms
Time Frame: Baseline; Week 1; Week 2; Week 3; Week 4
Food Sensitivity - Symptom Severity Scale (FS - SSS) is a 16-item questionnaire that will assess the severity of the patient's food sensitivity-related symptoms. The scores range from 0 (none) to 5 (severe).
Improvement in blood biomarker profile
Time Frame: Baseline - 4 weeks
The peptide and protein microarrays will be used to test patients' blood samples prior to and post-employment of the elimination diet, and changes in the blood biomarker profile will be monitored. Testing will be carried out at baseline and then after 4 weeks, on completion of the diet.
Secondary Outcomes
- Food sensitivity - Global Improvement Scale (FS-GIS)(Week 4)
- Food Sensitivity - Quality of Life Questionnaire (FS-QoL)(Baseline; Week 4)
Investigators
Hari Krishnamurthy
Director - Biomedical Engineering
Vibrant America Clinical Lab